Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
Moreau, Philippe, Prof, Pylypenko, Halyna, MD, Grosicki, Sebastian, MD, Karamanesht, Ievgenii, MD, Leleu, Xavier, MD, Grishunina, Maria, MD, Rekhtman, Grigoriy, MD, Masliak, Zvenyslava, MD, Robak, Tadeusz, Prof, Shubina, Anna, MD, Arnulf, Bertrand, MD, Kropff, Martin, MD, Cavet, James, MBBS, Esseltine, Dixie-Lee, MD, Feng, Huaibao, PhD, Girgis, Suzette, PhD, van de Velde, Helgi, MD, Deraedt, William, MSc, Harousseau, Jean-Luc, Prof
Published in The lancet oncology (01.05.2011)
Published in The lancet oncology (01.05.2011)
Get full text
Journal Article
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
Delforge, Michel, Prof, Bladé, Joan, Prof, Dimopoulos, Meletios A, Prof, Facon, Thierry, Prof, Kropff, Martin, MD, Ludwig, Heinz, Prof, Palumbo, Antonio, Prof, Van Damme, Philip, MD, San-Miguel, Jesús F, Prof, Sonneveld, Pieter, Prof
Published in The lancet oncology (01.11.2010)
Published in The lancet oncology (01.11.2010)
Get full text
Journal Article